Jonathan P. Lopez

Faculté De Médecine Lyon Est
Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapy.

Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: May 15, 2026

Mapping corpus callosum architecture: developmental, genetic, and cognitive correlates in youth.

Mapping corpus callosum architecture: developmental, genetic, and cognitive correlates in youth.

Journal: bioRxiv : the preprint server for biology

Published: May 07, 2026

Vascular and mesenchymal signatures of breast cancers associated with Yo and Ri paraneoplastic syndrome.

Vascular and mesenchymal signatures of breast cancers associated with Yo and Ri paraneoplastic syndrome.

Journal: Breast cancer research : BCR

Published: February 03, 2026

Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial).

Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial).

Journal: Immuno-oncology technology

Published: January 08, 2026

Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial).

Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial).

Journal: Immuno-oncology technology

Published: January 08, 2026

Eco-responsible and rational interval debulking surgery for high-grade ovarian carcinomas: An observational, ambispective cohort study.

Eco-responsible and rational interval debulking surgery for high-grade ovarian carcinomas: An observational, ambispective cohort study.

Journal: Gynecologic oncology

Published: November 10, 2025

Histomolecular Features of a Rare Subtype of Pleomorphic Adenoma Characterised by Abundant Lymphoid Stroma and HMGA2 Rearrangements.

Histomolecular Features of a Rare Subtype of Pleomorphic Adenoma Characterised by Abundant Lymphoid Stroma and HMGA2 Rearrangements.

Journal: Head and neck pathology

Published: October 10, 2025

Insights From Mutational and Transcriptomic Profiles in Epithelial-myoepithelial Carcinoma.

Insights From Mutational and Transcriptomic Profiles in Epithelial-myoepithelial Carcinoma.

Journal: The American journal of surgical pathology

Published: September 04, 2025

Prolonged response to lenvatinib in a poorly differentiated thyroid carcinoma with leptomeningeal carcinomatosis.

Prolonged response to lenvatinib in a poorly differentiated thyroid carcinoma with leptomeningeal carcinomatosis.

Journal: Annales d'endocrinologie

Published: June 26, 2025

Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements: Emphasis on the Possible Prognostic Significance of TERT Pathogenic Variants.

Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements: Emphasis on the Possible Prognostic Significance of TERT Pathogenic Variants.

Journal: The American journal of surgical pathology

Published: May 28, 2025

From hyperplasia to carcinoma: a molecular driven adrenal disease.

From hyperplasia to carcinoma: a molecular driven adrenal disease.

Journal: European journal of endocrinology

Published: February 10, 2025

Digenic Inheritance of Monoallelic MUTYH and POLE Germline Variants in Adrenocortical Carcinoma: Implications for Tumorigenesis and Immunotherapy.

Digenic Inheritance of Monoallelic MUTYH and POLE Germline Variants in Adrenocortical Carcinoma: Implications for Tumorigenesis and Immunotherapy.

Journal: Clinical genetics

Published: January 16, 2025

Showing 1-12 of 88

Last Updated: 09/26/2026